spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  transfusion 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 29 Aug 2023
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Aug 2023
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA
 HSMN NewsFeed - 12 Sep 2022
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
Devices Interventional Regulatory
 HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Feb 2022
MicroVention Announces First U.S. Patient Treated with FRED(TM) X(TM) Flow Diverter Featuring X Technology
Devices Interventional Neurosurgery
 HSMN NewsFeed - 22 Feb 2022
Vertos Medical Announces Results Showing Meaningful Mobility Improvement Following mild(R) Procedure
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Oct 2021
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Sep 2021
Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities
Diagnostics Product Launch
 HSMN NewsFeed - 2 Sep 2021
Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2021
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Devices Interventional Product Launch
 HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Apr 2021
Haemonetics Provides Update On U.S. Plasma Business
Devices
 HSMN NewsFeed - 20 Jan 2021
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Devices Neurosurgery FDA
 HSMN NewsFeed - 5 Jan 2021
Terumo Enters 100th Anniversary Year
Devices
 HSMN NewsFeed - 23 Dec 2020
MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC
Devices Interventional Litigation
 HSMN NewsFeed - 4 Nov 2020
Sobi launch Doptelet(R) (avatrombopag) in Europe
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 22 Sep 2020
MicroVention-Terumo Announces New Leadership
Devices Interventional Personnel
 HSMN NewsFeed - 7 Aug 2020
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Devices
 HSMN NewsFeed - 31 Jul 2020
CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
Devices
 HSMN NewsFeed - 15 Jul 2020
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Devices Interventional Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 May 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 May 2020
CytoSorb(R) is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
Devices Regulatory
 HSMN NewsFeed - 17 Apr 2020
Michael Coyle Joins Haemonetics Board of Directors
Devices Personnel
 HSMN NewsFeed - 2 Apr 2020
Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch
 HSMN NewsFeed - 14 Jan 2020
Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG(R) 6s Hemostasis Analyzer System
Devices Acquisitions
 HSMN NewsFeed - 9 Jan 2020
MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms
Devices Interventional Neurology FDA
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Nov 2019
Aruvant Appoints William Chou as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2019
FDA Clears ORTHO(TM) Sera ID-MTS for Use on the ORTHO VISION(R) Analyzer
Diagnostics FDA
 HSMN NewsFeed - 12 Sep 2019
Haemonetics Appoints Stewart W. Strong As President, Global Hospital
Devices Personnel
 HSMN NewsFeed - 27 Aug 2019
Zoll Medical Completes Acquisition of Cardiac Science
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2019
Instrumentation Laboratory Presents New GEM Premier ChemSTAT(TM) Testing System With iQM(R) At American Association For Clinical Chemistry Annual Meeting
Diagnostics Product Launch
 HSMN NewsFeed - 22 Jul 2019
Geron Enhances Oncology Expertise to Advance Corporate Objectives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jul 2019
Abbott Announces FDA Approval of the Alinity(TM) s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
Diagnostics FDA
 HSMN NewsFeed - 13 Jun 2019
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue(R) Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
Devices Interventional Licensing
 HSMN NewsFeed - 30 May 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA(R) (gilteritinib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2019
BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
Diagnostics FDA Product Launch
 HSMN NewsFeed - 13 Mar 2019
FDA Grants De Novo for the HemoSonics Quantra(R) QPlus System; This Revolutionary Diagnostic Provides Unique Information for Accessing Coagulation at the Point of Care; Now Commercially Available in US
Devices Diagnostics FDA
 HSMN NewsFeed - 6 Mar 2019
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
Diagnostics FDA
 HSMN NewsFeed - 12 Feb 2019
U.S. FDA Approves DARZALEX(R) (daratumumab) Split-Dosing Regimen
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 Jan 2019
Israeli Start-up Laminate, Developer of a Vascular Support Solution for Dialysis Patients, Has Completed a Capital Raising Round of $12 Million
Devices Venture Capital
 HSMN NewsFeed - 16 Jan 2019
Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox(R) Oxygenator
Devices Surgery Product Launch
 HSMN NewsFeed - 17 Oct 2018
Gauss raises $20 million in Series C from Northwell Health and SoftBank Ventures Korea for AI-Enabled Platform for the Operating Room
Devices Surgery Monitoring Venture Capital
 HSMN NewsFeed - 12 Oct 2018
FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Diagnostics FDA
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 21 Aug 2018
Siklos(R), the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Aug 2018
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals
 HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 7 Aug 2018
Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain
Devices Personnel
 HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2018
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Diagnostics FDA
 HSMN NewsFeed - 12 Jun 2018
MicroVention Announces FDA Clearance For Thrombectomy Device
Devices Interventional Neurology FDA
 HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2018
FDA Expands Lilly's ALIMTA(R) (pemetrexed) Label to Include Combination with KEYTRUDA(R) (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 May 2018
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
Diagnostics Product Launch
 HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA
 HSMN NewsFeed - 28 Mar 2018
Haemonetics Announces Regulatory Clearances of NexSys PCS(TM) Enhanced Software with YES(TM) Technology
Devices FDA Regulatory
 HSMN NewsFeed - 20 Mar 2018
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Mar 2018
CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2018
Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 25 Jan 2018
Ellen M. Zane Rejoins Haemonetics Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch
 HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Oct 2017
Robert E. Abernathy Joins Haemonetics Board of Directors
Devices Personnel
 HSMN NewsFeed - 14 Sep 2017
Haemonetics Appoints David J. Wilson Plasma Business Unit President
Devices Personnel
 HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2017
Haemonetics Announces FDA Clearance of New Plasmapheresis System Branded NexSys PCS(TM)
Devices FDA
 HSMN NewsFeed - 12 Jun 2017
Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement
Diagnostics Distribution
 HSMN NewsFeed - 6 Jun 2017
Ethicon Announces FDA Approval For SURGICEL(R) Powder Absorbable Hemostat
Devices Surgery FDA
 HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Oct 2016
FDA Clears VITROS(R) Automation Solutions from Ortho Clinical Diagnostics
Diagnostics FDA Product Launch
 HSMN NewsFeed - 7 Oct 2016
Fresenius Kabi Receives FDA 510(k) Clearance for the Aurora(TM) Xi Plasmapheresis System
Devices FDA
 HSMN NewsFeed - 2 Aug 2016
Ortho Clinical Diagnostics Announces Ortho Care
Diagnostics Product Launch
 HSMN NewsFeed - 29 Jul 2016
Micro Interventional Devices, Inc. Receives FDA Market Clearance for Permaseal(TM)
Devices Cardiology Surgery FDA
 HSMN NewsFeed - 18 May 2016
CytoSorb(R) Achieves Final Product Registration in Russia
Devices Distribution
 HSMN NewsFeed - 17 Feb 2016
Terumo Cardiovascular Group Introduces the CAPIOX(R) FX Advance Oxygenator
Devices Product Launch
 HSMN NewsFeed - 11 Jan 2016
Bioventus Board of Managers Appoints Bill Hawkins Chairman
Devices Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Approved by the European Commission as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Oct 2015
Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses
Devices Cardiology
 HSMN NewsFeed - 25 Sep 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Jul 2015
Sorin Group Announces Global Launch of Its Latest Generation of Heating and Cooling Systems at FECECT 2015
Devices Cardiology Product Launch
 HSMN NewsFeed - 1 Jul 2015
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
Devices Monitoring Regulatory
 HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 20 Feb 2015
REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2015
Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Dec 2014
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2014
First Ever Five-Millimeter Laparoscopic Stapled Small Bowel Anastomosis Performed With Cardica's MicroCutter XCHANGE(R) 30
Devices Surgery
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2014
Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and Efficient
Devices Surgery
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 14 Apr 2014
Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes
Diagnostics Endocrinology FDA
 HSMN NewsFeed - 31 Mar 2014
Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 17 Mar 2014
Edison Pharmaceuticals Announces Initiation of EPI-743 Pearson Syndrome Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 28 Jan 2014
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 27 Jan 2014
The Belmont(R) Rapid Infuser Expands Distribution to Japan
Devices Distribution
 HSMN NewsFeed - 16 Jan 2014
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2014
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2013
FDA Clears New Plasma Protocol Software for Fenwal Alyx(R) System
Devices FDA
 HSMN NewsFeed - 22 Oct 2013
Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Oct 2013
Verax Biomedical Closes $12MM Funding Round
Diagnostics Venture Capital
 HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2013
Bard Announces Agreement to Acquire Medafor, Inc.
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 31 Jul 2013
New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jul 2013
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
Devices Interventional Neurology
 HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2013
Thoratec Acquires DuraHeart(R) II Ventricular Assist System
Devices Cardiology Acquisitions
 HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Diagnostics Endocrinology Regulatory
 HSMN NewsFeed - 5 Apr 2013
Terumo Cardiovascular Systems Announces U.S. Distribution Agreement with Nonin Medical for Nonin's EQUANOX(TM) 7600 Regional Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Feb 2013
University of Virginia Medical Center Installs Masimo Noninvasive rainbow(R) Technologies to Improve Patient Assessments and Speed Clinical Decisions
Devices Monitoring
 HSMN NewsFeed - 13 Feb 2013
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2013
Fully Automatic AED Plus from ZOLL Granted 510(k) Clearance by U.S. Food and Drug Administration
Devices Cardiology FDA
 HSMN NewsFeed - 6 Feb 2013
ZOLL Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market Intravascular Temperature Management Technology
Devices Regulatory Distribution
 HSMN NewsFeed - 28 Jan 2013
Endologix Announces Presentation of Data From PEVAR Randomized Trial
Devices Interventional
 HSMN NewsFeed - 10 Jan 2013
New Study Shows Masimo Noninvasive & Continuous Total Hemoglobin (SpHb(R)) Monitoring Significantly Reduces Blood Transfusions and Costs in High Blood Loss Surgery
Devices Monitoring Surgery
 HSMN NewsFeed - 8 Jan 2013
InnoPharma, Inc. Announces U.S. FDA Approval of Acetylcysteine Injection
Biopharmaceuticals Distribution FDA
 HSMN NewsFeed - 4 Dec 2012
Sorin Group Receives PMDA Approval and Announces Commercial Launch of the Mitroflow(R) Aortic Pericardial Heart Valve in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 26 Nov 2012
Immunetics, Inc. Names John Yonkin as CEO
Diagnostics Personnel
 HSMN NewsFeed - 20 Nov 2012
Ipsen and Inspiration Biopharmaceuticals Announce That OBI-1 Has Received Fast Track Designation from FDA for Acquired Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2012
Sorin Group Announces the Acquisition of Neurotech, a Development-Stage Company Focused on Neurostimulation
Devices Cardiology Neurology Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2012
Sorin Group Announces U.S. Launch of New Heart Device for Simultaneous Implantation of an Aortic Tissue Valve and Ascending Aorta
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2012
ZOLL Establishes Japanese Subsidiary, Asahi Kasei ZOLL Medical
Devices
 HSMN NewsFeed - 16 Oct 2012
ZOLL Medical and GS GmbH (corpuls) Form Licensing Agreement to Incorporate ZOLL’s Real CPR Help in corpuls Defibrillators
Devices Cardiology Licensing
 HSMN NewsFeed - 12 Oct 2012
Masimo Unveils Fractional Arterial Oxygen Saturation, SpfO2, and rainbow SuperSensor
Devices Monitoring
 HSMN NewsFeed - 2 Oct 2012
Albany Medical Center Standardizes to Masimo rainbow SET Pulse CO-Oximetry(R)
Devices Monitoring
 HSMN NewsFeed - 26 Sep 2012
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Transfusion, Blood Donor Services, Equipment and Supplies
Devices Group Purchasing
 HSMN NewsFeed - 18 Sep 2012
Sorin Group Announces CE Mark Approval of Extended Indications and 2nd Generation Accessories for Perceval(TM) S
Devices Cardiology Surgery Regulatory
 HSMN NewsFeed - 13 Sep 2012
Sorin Group Receives SFDA Approval and Announces Commercial Launch of REPLY(TM) and ESPRIT(TM) Families of Pacemakers in China
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 Aug 2012
First Cardiac Surgery with Domain Surgical FMwand Completed at Beaumont Hospital
Devices Surgery
 HSMN NewsFeed - 7 Aug 2012
Masimo's Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery
Devices Monitoring Cardiology Surgery
 HSMN NewsFeed - 10 Jul 2012
Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
Devices Cardiology
 HSMN NewsFeed - 9 Jul 2012
Sorin Group Invests in Cardiosolutions, a Development-Stage Company Focused on Mitral Valve Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jul 2012
OrSense Introduces Glasswing(TM), its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for Anemia Screening
Devices Monitoring
 HSMN NewsFeed - 28 Jun 2012
CAS Medical Systems Announces Publication of Study Using FORE-SIGHT(R) to Improve Identification of Children With Sickle Cell Disease at Highest Risk for Neurologic Injury in Pediatric Blood and Cancer Journal
Devices Monitoring
 HSMN NewsFeed - 20 Jun 2012
CytoSorbents Appoints Dr. Christian Steiner as VP of Sales and Marketing and Hires Core Sales Force That Marks the Official Launch of CytoSorb(R) in Germany
Devices Personnel
 HSMN NewsFeed - 13 Jun 2012
Sorin Group and Orange Business Services Launch a Remote Monitoring Solution for Patients with Implanted Cardiac Devices in Europe
Devices Cardiology
 HSMN NewsFeed - 17 May 2012
Covidien Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett’s Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 16 May 2012
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 10 May 2012
Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads
Devices Cardiology FDA
 HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery
 HSMN NewsFeed - 21 Feb 2012
Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve
Devices Cardiology
 HSMN NewsFeed - 31 Jan 2012
Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads
Devices Cardiology Regulatory
 HSMN NewsFeed - 27 Jan 2012
Sorin Group Opens New International Training Center for Healthcare Professionals
Devices
 HSMN NewsFeed - 23 Jan 2012
Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 16 Jan 2012
Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2011
Medtronic Announces 510(k) Clearance for the Aquamantys(R)3 System with Combined Hemostatic Sealing and Cutting Functionality
Devices FDA
 HSMN NewsFeed - 17 Oct 2011
Sorin Group Invests in Enopace Biomedical, Early Stage Company Focused on Innovative Solution for Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 12 Oct 2011
Sorin Group Launches SonR(R) Sensor Based Cardiac Resynchronization Therapy (CRT) Optimization System (1)
Devices Cardiology
 HSMN NewsFeed - 6 Oct 2011
William A. Hawkins Appointed New CEO of Immucor
Diagnostics Personnel
 HSMN NewsFeed - 15 Sep 2011
Court Rules in Favor of Fenwal in Nearly 6-Year U.S. Patent Dispute with Haemonetics
Devices Litigation
 HSMN NewsFeed - 14 Sep 2011
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jul 2011
Sorin Group Receives CE Mark Approval for the Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment
Devices Cardiology Regulatory
 HSMN NewsFeed - 19 Jul 2011
Sorin Group Announces Purchase of Estech Cannulae Product Line
Devices Cardiology Acquisitions
 HSMN NewsFeed - 1 Jun 2011
ORTHOCON(R), Inc. Receives 510(k) Clearance to Market HEMASORB Apply
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 24 May 2011
Sorin Group Announces First North American Implant of the Freedom Solo Pericardial Aortic Valve
Devices Cardiology
 HSMN NewsFeed - 2 May 2011
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
Devices Interventional
 HSMN NewsFeed - 29 Apr 2011
Sorin Group Announces U.S. Launch of XTRA(R) Autotransfusion System
Devices Surgery
 HSMN NewsFeed - 21 Apr 2011
ORTHOCON(R) Receives CE Mark and Health Canada Medical Device License for HEMASORB(R)
Devices Orthopaedic Surgery Regulatory
 HSMN NewsFeed - 20 Apr 2011
Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 11 Apr 2011
Orthovita Announces Presentation of Clinical Results Evaluating Vitagel(TM) Surgical Hemostat in Reducing Blood Loss During Primary Unilateral Total Knee Arthroplasty
Devices Orthopaedic Surgery
 HSMN NewsFeed - 24 Feb 2011
Sorin Group Invests in MD Start, the First Independent European-Based Medtech Accelerator
Devices Venture Capital
 HSMN NewsFeed - 21 Feb 2011
Sorin Group Announces the Achievement of a Key Milestone in Aortic Valve Replacement
Devices Cardiology
 HSMN NewsFeed - 17 Feb 2011
ORTHOCON(R) Announces U.S. Market Launch of HEMASORB(R)
Devices Surgery Orthopaedic
 HSMN NewsFeed - 31 Jan 2011
Sorin Group Receives CE Mark Approval for the Innovative Self-Anchoring Aortic Heart Valve, Perceval(TM) S
Devices Cardiology Regulatory
 HSMN NewsFeed - 26 Jan 2011
Medicare Europe announces a new partnership with the largest cardiology centre in Ukraine and Eastern Europe – Kyiv Municipal Heart Centre
Hospitals & Healthcare Systems Cardiology
 HSMN NewsFeed - 10 Jan 2011
ORTHOCON(R) Names John J. Pacifico President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 15 Nov 2010
Rivaroxaban Significantly Reduces Risk of Stroke in Patients With Atrial Fibrillation With Comparable Safety vs. Warfarin in Pivotal Phase 3 Study
Biopharmaceuticals Cardiology Neurology
 HSMN NewsFeed - 1 Nov 2010
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay
Diagnostics FDA
 HSMN NewsFeed - 22 Oct 2010
Sorin Group Announces Full and Final Settlement of Investigation by Department of Justice
Devices Cardiology
 HSMN NewsFeed - 20 Oct 2010
Salient Surgical’s New AQUAMANTYS3 System with Advanced Cutting and Hemostatic Sealing Device Proves Successful in First Surgical Case
Devices Surgery
 HSMN NewsFeed - 18 Oct 2010
Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers
Devices Distribution
 HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Sep 2010
Terumo Medical Corporation Announces First U.S. Patient Implant in Landmark Pilot Study Simultaneously Enrolling in the U.S. & Japan
Devices Interventional
 HSMN NewsFeed - 31 Aug 2010
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Aug 2010
FDA Grants Fenwal New 510(k) Clearance
Devices FDA
 HSMN NewsFeed - 2 Aug 2010
Haemonetics Announces Future Retirement Date of Board Chairman Brad Nutter
Devices Personnel
 HSMN NewsFeed - 16 Jul 2010
Biomet Announces Acquisition of Substantially All of the Assets of Cytosol Laboratories, Inc.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2010
Masimo Initiates Limited Market Release of Pronto-7(TM) -- New Revolutionary Palm-sized Device for Noninvasive Hemoglobin Spot-Check Testing at the Point-of-Care
Devices Monitoring
 HSMN NewsFeed - 17 Jun 2010
Sorin Group: CLEAR Study Demonstrates Automatic Optimization of CRT with SonR Improves Heart Failure Patients Response Rates
Devices Cardiology
 HSMN NewsFeed - 16 Jun 2010
New Study Presented at European Society of Anaesthesia Validates Masimo Noninvasive and Continuous Hemoglobin Monitoring
Devices Monitoring
 HSMN NewsFeed - 8 Jun 2010
Sorin Group Acquires Gish Biomedical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 2 Jun 2010
MAQUET Cardiovascular Receives 510(k) Marketing Clearance for QUADROX-iD Pediatric Diffusion Membrane Oxygenator
Devices Cardiology Surgery FDA
 HSMN NewsFeed - 28 May 2010
Roche Diagnostics Receives FDA Approval for Qualitative Anti-HCV Immunoassay Test on Three Analyzer Platforms
Diagnostics FDA
 HSMN NewsFeed - 27 May 2010
CORDIS Launches ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 19 May 2010
Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease
Diagnostics FDA
 HSMN NewsFeed - 12 May 2010
Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
Devices Interventional FDA
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2010
Sorin Group Announces Distribution Agreement with Cardiomedical GmbH for Cardio Vision(TM) Range of Minimally Invasive Surgical Instruments
Devices Cardiology Surgery Distribution
 HSMN NewsFeed - 28 Apr 2010
Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
Devices FDA
 HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Apr 2010
Sorin Group Sells Angel Whole Blood Separation System and activAT(R) Autologous Thrombin Processing Kit to Cytomedix
Regenerative Medicine Acquisitions
 HSMN NewsFeed - 22 Mar 2010
Board of Directors to Evaluate Request for Exclusive Due Diligence for the Purpose of Launching a Possible Public Offer on Sorin S.p.A.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2010
FDA Provides 510k Clearance for BARRX Medical's HALO90 Ablation Catheter for the Treatment of Radiation Proctitis and Gastric Antral Vascular Ectasia (GAVE)
Devices Gastroenterology FDA
 HSMN NewsFeed - 3 Mar 2010
CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System
Devices FDA
 HSMN NewsFeed - 18 Feb 2010
Sorin Group Announces U.S. FDA Clearance of Newest Generation Heart Lung-Machine
Devices Cardiology FDA
 HSMN NewsFeed - 16 Feb 2010
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2010
Sorin Group Announces Market Release and First Implant of Next-Generation Cardiac Resynchronization Therapy Defibrillator
Devices Cardiology
 HSMN NewsFeed - 1 Feb 2010
Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2010
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Dec 2009
Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2009
VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 14 Oct 2009
Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
Diagnostics FDA HIV/AIDS
 HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2009
MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
Devices Surgery Cardiology
 HSMN NewsFeed - 22 Sep 2009
FDA Clears Sysmex XE-2100D Hematology Analyzer for Blood Processing Center Quality Control Release Testing
Diagnostics FDA
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Aug 2009
Cerus' INTERCEPT Blood System for Platelets Receives Swiss Approval
Devices Regulatory
 HSMN NewsFeed - 15 Jul 2009
Baxter and Halozyme Announce Completion of Patient Enrollment in Phase III Pivotal Trial of GAMMAGARD LIQUID with rHuPH20 Enzyme
Biopharmaceuticals
 HSMN NewsFeed - 7 Jul 2009
Sorin Group Announces World's Smallest Implantable Dual Chamber Pacemaker Now Available in Canada
Devices Cardiology Regulatory
 HSMN NewsFeed - 3 Jul 2009
Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 24 Jun 2009
Sorin Group Announces European Market Release and First Implant of Its New-Generation Dual Chamber Implantable Cardioverter Defibrillator
Devices Cardiology
 HSMN NewsFeed - 26 May 2009
FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2009
Molecular Diagnostics Company, RedPath, Appoints Dennis M. Smith, Jr., M.D. as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 May 2009
New Label Claim Expands Market for Cerus' INTERCEPT Blood System
Devices Regulatory
 HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Apr 2009
Haemonetics Expands Its Blood Management Leadership With Acquisition of Neoteric Technology Ltd
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2009
Sorin Group Announces European Market Release of the Esprit Pacemaker Family
Devices Cardiology Regulatory
 HSMN NewsFeed - 1 Apr 2009
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Mar 2009
Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor
Devices Monitoring
 HSMN NewsFeed - 23 Mar 2009
U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'RESUS' Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2009
Sorin Group Announces Start of Patient Enrolment in 'Perceval S' Sutureless Aortic Valve Clinical Trial in Europe
Devices Cardiology
 HSMN NewsFeed - 16 Feb 2009
Cardinal Health Announces New Name for Spinoff Company
Devices
 HSMN NewsFeed - 9 Feb 2009
Sorin Group Acquires Endoscopic Vessel Harvesting Business from Datascope, Inc.
Devices Cardiology Surgery Acquisitions
 HSMN NewsFeed - 30 Jan 2009
REVLIMID Receives Preliminary Positive Recommendation from National Institute for Health and Clinical Excellence (NICE) for Use in the National Health Service (NHS) in England and Wales
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Jan 2009
Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jan 2009
Immucor Announces New Vice President, Operations
Diagnostics Personnel
 HSMN NewsFeed - 31 Dec 2008
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
Diagnostics FDA
 HSMN NewsFeed - 30 Dec 2008
U.S. Navy Requested Operations Trial on FDA Hold
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2008
ConvaTec and Boehringer Technologies Announce License Agreement
Devices Wound Care Licensing
 HSMN NewsFeed - 9 Dec 2008
Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Dec 2008
Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Oct 2008
Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
Devices Personnel
 HSMN NewsFeed - 24 Oct 2008
Cancer Drug Vidaza(R) Receives Positive Opinion from European Regulatory Authority for Treatment of MDS and AML
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Oct 2008
Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization from Health Canada for Treatment of Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Sep 2008
FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2008
Sorin Group Announces First Successful Uses of New Pediatric Oxygenator and Arterial Filter at Children's Medical Center Dallas
Devices Cardiology
 HSMN NewsFeed - 2 Sep 2008
Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Cardiovascular LLC
Devices Litigation
 HSMN NewsFeed - 27 Aug 2008
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Aug 2008
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Aug 2008
Cerus' INTERCEPT Blood System Receives CE Mark Label Expansion for Treatment of Previously Frozen Plasma
Devices Regulatory
 HSMN NewsFeed - 9 Jul 2008
Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
Devices Cardiology Litigation
 HSMN NewsFeed - 7 Jul 2008
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jun 2008
FDA Clears First Automated Whole Blood Processing System in U.S.
Devices FDA
 HSMN NewsFeed - 13 Jun 2008
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jun 2008
VIDAZA(R) Continues to Show Significant Overall Survival Benefit When Compared with Conventional Care Regimens Across the EU
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2008
Cerus Enters into Agreement to Supply INTERCEPT Platelet System to Largest Region of German Red Cross
Devices
 HSMN NewsFeed - 4 Jun 2008
Gambro BCT Soon to Become CaridianBCT
Devices
 HSMN NewsFeed - 3 Jun 2008
Study of VIDAZA(R) in Higher-Risk Myelodysplastic Syndrome Patients Demonstrates Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Celgene Withdraws European Union (EU) Marketing Authorization Application for Lenalidomide in Deletion-5Q Myelodysplastic Syndromes
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 May 2008
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
Devices Monitoring FDA
 HSMN NewsFeed - 12 May 2008
Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery
Devices Product Recall
 HSMN NewsFeed - 5 May 2008
Cardica's C-Port(R) Flex A(R) Anastomosis System Facilitates Groundbreaking Port Only Robotic Beating Heart Bypass Surgery
Devices Surgery Cardiology
 HSMN NewsFeed - 21 Apr 2008
Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System
Devices Regulatory
 HSMN NewsFeed - 18 Apr 2008
CardiacAssist, Inc. Announces Five New TandemHeart Centers of Excellence
Devices Cardiology
 HSMN NewsFeed - 11 Apr 2008
ALIMTA(R) (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Apr 2008
Roche Diagnostics Expands Availability of HCV Immunoassay
Diagnostics Regulatory
 HSMN NewsFeed - 7 Apr 2008
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Apr 2008
Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
Devices Cardiology Litigation
 HSMN NewsFeed - 2 Apr 2008
European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Mar 2008
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
Devices Personnel
 HSMN NewsFeed - 20 Mar 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
 HSMN NewsFeed - 13 Mar 2008
Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2008
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Mar 2008
Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
Devices Personnel
 HSMN NewsFeed - 11 Mar 2008
Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2008
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2008
EU Commission Approves Updated Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Mar 2008
CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Mar 2008
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Mar 2008
Cerus Promotes Laurence M. Corash, M.D. to Senior Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 20 Feb 2008
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2008
Lenalidomide (REVLIMID(R)) Receives Orphan Drug Status in Japan for Multiple Indications
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Feb 2008
MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Feb 2008
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Feb 2008
Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Feb 2008
MethylGene and Pharmion Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Feb 2008
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Jan 2008
FDA Grants Priority Review For Velcade(R) (bortezomib) for Injection In Patients with Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jan 2008
Hospitals, Healthcare Providers to Save with Premier's New Orthopedic Autotransfusion Systems Agreements
Devices Group Purchasing
 HSMN NewsFeed - 28 Jan 2008
Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
Devices Interventional
 HSMN NewsFeed - 24 Jan 2008
Celgene Reports on REVLIMID(R) (Lenalidomide) Global Regulatory Developments in Multiple Myeloma and Deletion 5Q Myelodysplastic Syndromes
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jan 2008
Brad Nutter Named Chairman of the Board of Haemonetics
Devices Personnel
 HSMN NewsFeed - 14 Jan 2008
Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Dec 2007
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 20 Dec 2007
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2007
Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Dec 2007
Medtronic and Weigao Announce Joint Venture in China
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Dec 2007
Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R)
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2007
Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals
 HSMN NewsFeed - 9 Dec 2007
Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
SWOG Phase III Trial Reports REVLIMID(R) (lenalidomide) Plus Dexamethasone Achieves Superior Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
REVLIMID(R) (Lenalidomide) Plus Low-Dose Dexamethasone Achieves Unprecedented Survival Rate in ECOG Phase III Trial in Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Dec 2007
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Announces Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2007
Lenalidomide (REVLIMID(R)) Receives Orphan Medicinal Product Designation from the European Commission for Chronic Lymphocytic Leukemia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Nov 2007
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Nov 2007
Health Canada Licenses QIAGEN's New Molecular Test for Hepatitis B
Diagnostics Regulatory
 HSMN NewsFeed - 12 Nov 2007
Cancer Drug REVLIMID(R) Receives Recommendation for Approval from Australian Drug Evaluation Committee for Treatment of Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 8 Nov 2007
Haemonetics Appoints Executive Leadership of European Operations
Devices Personnel
 HSMN NewsFeed - 8 Nov 2007
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 8 Nov 2007
Amgen Announces Updates to the U.S. Prescribing Information for ESAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Nov 2007
Prometheus to Acquire Lotronex(R) From GlaxoSmithKline
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 1 Nov 2007
HemaQuest Announces $20M Series A Financing for Anemia Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Oct 2007
Haemonetics Expands Its Blood Management Leadership With Acquisition Of Haemoscope Business Unit
Devices Diagnostics Acquisitons
 HSMN NewsFeed - 17 Oct 2007
Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
Devices Personnel
 HSMN NewsFeed - 16 Oct 2007
Terumo Interventional Systems Launches New Radial Artery Compression Device
Devices Interventional
 HSMN NewsFeed - 15 Oct 2007
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 15 Oct 2007
Biopure Announces Expanded Clinical Program To Target Anemia
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Sep 2007
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Sep 2007
Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Sep 2007
Updated REVLIMID(R) Clinical Results Presented at the 12th International Workshop on Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Sep 2007
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Sep 2007
Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Sep 2007
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 4 Sep 2007
Oral Cancer Drug REVLIMID(R) Receives Swissmedic Approval in Switzerland for Treatment of Multiple Myeloma
Biopharmaceuticals Regulatory Oncology
 HSMN NewsFeed - 29 Aug 2007
Edwards Lifesciences Introduces First Real-Time, Continuous Central Venous Oxygenation Saturation Monitoring Technology for Critically Ill Children
Devices Monitoring
 HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 28 Aug 2007
FDA Approves New Roche West Nile Virus Blood Screening Test
Diagnostics FDA
 HSMN NewsFeed - 28 Aug 2007
MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Aug 2007
Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2007
Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2007
Accentia Biopharmaceuticals Files Pre-Investigational New Drug (IND) Application with FDA for Pivotal Phase 3 Clinical Trial of Revimmune for Refractory Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jul 2007
Millennium Initiates Phase III Trial to Determine the Optimal VELCADE(R) (Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jul 2007
VELCADE(R) (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jun 2007
Cerner Receives FDA Clearance for Cerner Bridge Transfusion Administration and Specimen Collections
Devices FDA
 HSMN NewsFeed - 26 Jun 2007
Amgen Submits Testimony to House Ways & Means Committee
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 26 Jun 2007
Cerus Announces Agreement to Supply the INTERCEPT Blood System for Platelets to French National Blood Service
Devices
 HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2007
Immucor's Echo Cleared by FDA for Marketing in U.S.
Diagnostics FDA
 HSMN NewsFeed - 19 Jun 2007
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2007
Daxor Announces Oklahoma VA Medical Center of Oklahoma City, OK Acquires BVA-100 Blood Volume Analyzer
Devices
 HSMN NewsFeed - 4 Jun 2007
New Data on Market-Leading VELCADE(R) (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Substantially Improves Event-Free Survival and Complete Response Rate in Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
VELCADE(R) (bortezomib) for Injection Based Therapies Produced High Complete Response Rates in Newly Diagnosed Non-Hodgkin's Lymphoma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Study Presented at ASCO Shows Encouraging One-Year and Overall Survival Results for Phase I/II Trial of OGX-011 in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2007
Zebra Technologies Introduces New Adhesive Tab Closure on Its Z-Band Direct(R) Antimicrobial Patient Wristbands
Devices
 HSMN NewsFeed - 29 May 2007
Infant is First to Undergo Minimally Invasive Neurosurgery Procedure With Viking Systems' 3D Surgical Vision System
Devices Neurosurgery
 HSMN NewsFeed - 15 May 2007
SWOG Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 May 2007
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
Biopharmaceuticals Surgery Cardiology
 HSMN NewsFeed - 8 May 2007
Sanguine Continues Work Toward FDA 510(k) Application
Devices FDA
 HSMN NewsFeed - 3 May 2007
Sernova Directors and Management Established for 2007/2008-Dr. George Adams Named Chair; Justin Leushner Becomes CEO
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2007
CHMP Adopts Positive Opinion for Alexion's Soliris(TM) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Apr 2007
PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in Intravenous Steroid-Refractory Ulcerative Colitis
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Apr 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Apr 2007
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2007
Globus Medical Announces First Posterior Disc Replacement
Devices Orthopaedic
 HSMN NewsFeed - 4 Apr 2007
ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Mar 2007
Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2007
Update: FDA Approves Alexion's Soliris(TM) for All Patients With PNH
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2007
FDA Approves Alexion's Soliris(TM) for All Patients With PNH
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2007
Alliance Pharmaceutical Corp. Updates Clinical Development of Oxygent(TM) in China
Biopharmaceuticals
 HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Mar 2007
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
Oncology
 HSMN NewsFeed - 5 Mar 2007
A Major Study Compares Direct Blood Volume Measurement Using the BVA-100 With the BNP Test for Managing Fluid Therapy in the Intensive Care Unit
Devices
 HSMN NewsFeed - 1 Mar 2007
Fenwal Launched as Independent Corporation Following Completion of Divestiture From Baxter Healthcare Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2007
Baxter Completes Sale of Transfusion Therapies Business
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2007
Seattle Genetics Receives Orphan Drug Designations for its SGN-33 and SGN-35 Programs
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2007
Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical Trials
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jan 2007
Independent Study Concludes Masimo Engineering Prototype Is the First Technology to Measure Total Hemoglobin Continuously and Noninvasively, Wins STA Technology Award
Devices Monitoring
 HSMN NewsFeed - 25 Jan 2007
Verax Biomedical Appoints James Koziarz, Ph.D. to Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 25 Jan 2007
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
Biopharmaceuticals
 HSMN NewsFeed - 22 Jan 2007
Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jan 2007
New Transfusion Therapies Company to Be Named 'Fenwal'
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2007
Roche Diagnostics Submits West Nile Virus Blood Screening Test to FDA
Diagnostics
 HSMN NewsFeed - 17 Jan 2007
Cerus Announces French Regulatory Approval of the INTERCEPT Blood System for Plasma
Devices Regulatory
 HSMN NewsFeed - 12 Jan 2007
AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2007
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Jan 2007
ELAD(R) Bioartificial Liver Trial in China Achieves Significance at Halfway Point
Devices
 HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2007
Radius Appoints Nick Harvey Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2006
Biopure Announces Next Steps for Navy's Proposed 'Resus' Trauma Trial of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 19 Dec 2006
Northfield Laboratories Reports Preliminary Top-Line Data in Pivotal Phase III Trauma Study
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2006
Bayer Pharmaceuticals Corporation Informs Health Care Professionals of Important Safety Revisions to the Trasylol Label
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Five Senior Executives to Join New Transfusion Therapy Company
Devices Personnel Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2006
Dr. Bob Tepper, President of R&D, to Leave Millennium
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
Ortho-Clinical Diagnostics Receives FDA Approval for First Blood-Screening Test for Chagas' Disease
Diagnostics FDA
 HSMN NewsFeed - 13 Dec 2006
Trimedyne Raises $3 Million to Finance an Expected Increase in Sales of New Laser Fiber
Devices
 HSMN NewsFeed - 12 Dec 2006
VELCADE(R) (bortezomib) for Injection Incorporated Into NCCN(R) Clinical Practice Guidelines for Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
VELCADE(R) (Bortezomib) for Injection Demonstrates Substantial Activity Across Range of Lymphomas
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Positive Results from Combination Trials Build on VELCADE(R) (Bortezomib) for Injection Proven Single-Agent Strength in Relapsed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Multiple Myeloma Patients Respond to Retreatment with VELCADE(R) (Bortezomib) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
Eculizumab is Well Tolerated and Demonstrates Significant Improvement During 52 Weeks of Treatment in Open-Label Phase III SHEPHERD Study in PNH Patients
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2006
VELCADE(R) (Bortezomib) for Injection Combination Shows High Complete and Near Complete Response Rate in Preliminary Data From Phase III Front-Line Multiple Myeloma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2006
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2006
Majority of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Amgen Submits Testimony to House Ways & Means Committee
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2006
RITA Medical Systems Announces Market Release of Habib 4X Laparoscopic(TM)
Devices Surgery
 HSMN NewsFeed - 28 Nov 2006
AngioDynamics to Acquire RITA Medical for $220 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2006
Cerus Corporation Announces European Regulatory Approval for the INTERCEPT Blood System for Plasma
Devices Regulatory
 HSMN NewsFeed - 21 Nov 2006
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Nov 2006
Neoteric Technology Ltd. Receives U.S. FDA Marketing Clearance for Blood Management Products
Devices FDA
 HSMN NewsFeed - 1 Nov 2006
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2006
Premier Purchasing Partners Signs New Agreements for Transfusion Donor Services, Equipment, Supplies
Devices Group Purchasing
 HSMN NewsFeed - 26 Oct 2006
RITA Medical Initiates Feasibility Study of Device for RFA-Assisted Breast Lumpectomy
Devices Oncology
 HSMN NewsFeed - 20 Oct 2006
Abbott Signs Exclusive Worldwide Distribution Agreement With Verax Biomedical for Rapid Platelet Bacteria Test
Diagnostics Distribution
 HSMN NewsFeed - 18 Oct 2006
Haemonetics Launches Automated, Self-Regulating Surgical Suction Device in U.S.
Devices Surgery
 HSMN NewsFeed - 17 Oct 2006
RITA Medical Systems Announces FDA 510(k) Clearance of HABIB 4X Laparoscopic(TM) Device
Devices Surgery FDA
 HSMN NewsFeed - 13 Oct 2006
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2006
Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2006
RITA Medical Highlights Recent Clinical Publications Discussing Local Therapy Devices in the Treatment of Liver Tumors Associated With Colorectal Cancer
Devices Oncology
 HSMN NewsFeed - 2 Oct 2006
Updated REVLIMID(R) (lenalidomide) Clinical Results Presented at the 3rd International Conference on Innovative Therapies for Lymphoid Malignancies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Oct 2006
Hollis-Eden Pharmaceuticals Provides Update on Bone Marrow Regeneration Program and Chemotherapy Indication
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 29 Sep 2006
Bayer Acknowledges That New Trasylol Study Was Not Disclosed Prior to Recent FDA Cardio-Renal Advisory Committee Meeting
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Sep 2006
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Aug 2006
ADVENTRX Appoints Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2006
KARL STORZ Prepares for Launch of the New Bipolar Resectoscope and AUTOCON(R) II 400 ESU
Devices Surgery
 HSMN NewsFeed - 12 Jul 2006
Biopure Comments on Wall Street Journal Articles
Biopharmaceuticals
 HSMN NewsFeed - 11 Jul 2006
RITA Announces Launch of LC Bead(TM) Embolization Product in U.S.
Devices Oncology
 HSMN NewsFeed - 11 Jul 2006
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jun 2006
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jun 2006
FDA Approves SPRYCEL(TM) (dasatinib) With Two Indications
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2006
For Patients, Inc.'s CathSling(tm) has been approved for Medicare Reimbursement
Devices Reimbursement
 HSMN NewsFeed - 14 Jun 2006
ThermoGenesis Expands European Distribution of CryoSeal(R) Fibrin Sealant (FS) System and Thrombin Processing Device(TM) (TPD) to Czech Republic, Slovakia and Greece
Devices Surgery Distribution
 HSMN NewsFeed - 13 Jun 2006
Pharmion Corporation Announces FDA Acceptance of Vidaza NDA Supplement for IV Administration for Filing and Grants Six Month Review Goal
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jun 2006
Haemonetics to Acquire Arryx in $26 Million Transaction
Devices Mergers & Acquisitions
 HSMN NewsFeed - 5 Jun 2006
REVLIMID(R) (Lenalidomide) Evaluated as Combination Oral Treatment Regimen in Elderly Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2006
Interim Data Suggest Potential Benefits of Aranesp(R) Dosed Every Three Weeks with Intravenous Iron for Chemotherapy-Induced Anemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2006
Study Explores Use of PROCRIT(R) (Epoetin Alfa) Once Every Two Weeks As Initiation Treatment for Chemotherapy-Related Anemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2006
Threshold Announces Data Safety Monitoring Board Recommends Glufosfamide Phase 3 Clinical Trial Continue to Completion
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 May 2006
MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2006
Boston Scientific and Lumenis to Market Trimedyne's New Fiber
Devices Urology
 HSMN NewsFeed - 18 May 2006
Large Head-to-Head Study of Aranesp(R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published in the Journal of Clinical Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2006
Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2006
U.S. FDA Approves Dacogen(TM) (Decitabine) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Apr 2006
RITA Medical Acquires Exclusive U.S. and Canada Distribution Rights to the Biocompatibles LC Bead(TM) Embolization Product
Devices Oncology Distribution
 HSMN NewsFeed - 26 Apr 2006
Inspire Announces Initiation of Phase 2 Clinical Trial of Platelet Aggregation Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Apr 2006
FDA Approves Humanitarian Device Exemption for Instrument Set to Treat Rare Disorder Affecting Fetal Twins -- KARL STORZ Device Offers Unique Treatment Option for Twin-to-Twin Transfusion Syndrome
Devices FDA
 HSMN NewsFeed - 25 Apr 2006
First FDA Clearance of Sterile Field Cord Blood Collection Bag
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 17 Apr 2006
Terumo Cardiovascular Systems and Harvest Technologies Corporation Announce Exclusive Distributorship in the Cardiovascular Market for Harvest's SmartPReP(R)2 Platelet Concentration System
Devices Cardiology Distribution
 HSMN NewsFeed - 13 Apr 2006
Medtronic Enters Heart-Lung Machine Market with Most Advanced, Compact Circulatory Support System
Devices Surgery Cardiology FDA
 HSMN NewsFeed - 12 Apr 2006
Immucor Announces Capture-S (Syphilis) and CMV Assays Have Been Cleared by the FDA for Use on the Galileo
Diagnostics FDA
 HSMN NewsFeed - 7 Apr 2006
REVLIMID(R) Marketing Authorization Application Accepted by EMEA for Review
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Apr 2006
Teva Announces Approval of Deferoxamine Mesylate for Injection USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2006
Pharmion Corporation Announces Submission of Vidaza NDA Supplement for IV Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Mar 2006
RITA Medical Systems Provides Comment on New CIGNA Healthcare Coverage for Radiofrequency Ablation (RFA) in Certain Lung Cancer Cases
Devices Oncology Reimbursement
 HSMN NewsFeed - 27 Mar 2006
Masimo Announces the FDA Clearance of Masimo Rainbow SET Rad-57cm
Devices FDA Monitoring
Return to NewsFeed  

 Additional items found! 272

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 272 additional stories matching:
transfusion
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.